Clinical Trial Update: Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluated autologous T-cell transplantation and vaccine-driven T-cell expansion after dose-intensive chemotherapy in breast cancer. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Neoplasm, Neoplasm Metastasis | Phase 1 | Status: COMPLETED